The overall objective of the instrumentation project is the prototype development of user-friendly detection/imaging hardware with informatics software to support high throughput mRNA analyses of lung tissue samples in a microarray microtiter-based format. The custom instrumentation to be developed for the Program Project is based on the proximal CCD detection/imaging technology established at Genometrix under both federal (DOC/ATP, NIH, NASA) and private (venture capital, corporate partners) funding. The functional specifications for the instrumentation developed for the Program Project will facilitate high sensitivity for chemiluminescent and fluorescent labeling, aray multiplexing, high throughput, automated quantitation, and information processing. Specifically, the instrumentation workstation will accommodate both the fluorescent and chemiluminescent labeling formats proposed in Project 1. Several motifs utilizing Eu/+3 chelators will be accommodated including linkage to beads in a sandwich assay, covalent attachment to mRNA, and simple sandwich assays using enzyme linked fluorescence. The proposed proximal CCD detection system will be automatically time gated to reduce background fluorescence. The proposed proximal CCD detection system will be automatically time gated to reduce background fluorescence, thereby taking full advantage of the long emission lifetimes characteristics of the chelating compounds. Also dioxitane chemiluminescent labeling will be employed wherein both linkage to detector probes and to beads in a sandwich assay will be accommodated. Finally, the informatics component of the workstation involves converting the pattern of array binding patterns into relative mRNA concentrations. Approaches to be investigated for this deconvolution problem include conventional statistical correlation analysis as well as neural networks and multicomponent maximum entropy methods. Following prototype development, the above instrumentation will be made available to scientists in Core A for use by all Program Project members. Also the workstations will be built in close collaboration with Program Project members, (especially members from Project 1, Core A and B) to ensure high compatibility with the multiparameter lung tissue mRNA analyses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA074173-01A1
Application #
6269825
Study Section
Project Start
1998-03-01
Project End
1998-12-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Wang, X; Wang, L; Callister, M D et al. (2001) Human Rad17 is phosphorylated upon DNA damage and also overexpressed in primary non-small cell lung cancer tissues. Cancer Res 61:7417-21
Soria, J C; Moon, C; Wang, L et al. (2001) Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst 93:1257-63
Jang, S J; Soria, J C; Wang, L et al. (2001) Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61:7959-63
Wu, W G; Soria, J C; Wang, L et al. (2000) TRAIL-R2 is not correlated with p53 status and is rarely mutated in non-small cell lung cancer. Anticancer Res 20:4525-9
Soria, J C; Jang, S J; Khuri, F R et al. (2000) Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60:4000-4
Jang, S J; Mao, L (2000) Methylation patterns in human androgen receptor gene and clonality analysis. Cancer Res 60:864-6
Wang, L; Lin, S H; Wu, W G et al. (2000) C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Clin Cancer Res 6:2988-93
Jing, N; De Clercq, E; Rando, R F et al. (2000) Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design. J Biol Chem 275:3421-30
Wu, W; Kemp, B L; Proctor, M L et al. (1999) Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 59:1846-51
Wu, W; Fan, Y H; Kemp, B L et al. (1998) Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res 58:4082-5